Sangie Pharmaceuticals Private Limited
About Sangie Pharmaceuticals Private Limited
Data last updated:
Sangie Pharmaceuticals Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 30 December 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74900MH2014PTC260498. Its GSTIN is 27AAVCS2837H1ZS (Maharashtra). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Snehdeep Surajbhan Kaushik and Olga Madmarova.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Thane, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹13.57 Lakh, a decline of 80% compared to the previous year. For the same year it recorded a net loss of ₹25.89 Lakh (net margin -190.8%) and EBITDA of -₹25.89 Lakh (EBITDA margin -190.8%). Revenue has declined at a compounded annual rate (CAGR) of 68% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Sangie Pharmaceuticals Private Limited's registered office is in Thane, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressFlat No. 304 Bldg No. 341 Sect 3 Kalptaru Srishti Mira Road Surya Shopp, Ing Centre, Thane, Maharashtra, India – 401107
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Sangie Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Sangie Pharmaceuticals Private Limited
FY 2025 filings availableSangie Pharmaceuticals Private Limited reported revenue of ₹13.57 Lakh (down 80% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 68% over three years, including a 80% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹25.89 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹25.89 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -190.8% | ||||
| Net Profit Margin | -190.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sangie Pharmaceuticals Private Limited, buy the company report.
Board of directors of Sangie Pharmaceuticals Private Limited
Sangie Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Snehdeep Surajbhan Kaushik | Director | 30 Dec 2014 | 11 Years 10 Months | Current |
| Olga Madmarova | Director | 30 Dec 2014 | 11 Years 10 Months | Current |
Auditor
Sangie Pharmaceuticals Private Limited is audited by T LAKDAWALA & ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| T LAKDAWALA & ASSOCIATES | FY 2022 | 139196W |
Shareholding
The shareholding of Sangie Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Sangie Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Sangie Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sangie Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sangie Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAVCS2837H1ZS | Maharashtra | Active | 27 Apr 2021 |
To see the full GST registrations and return filing status of Sangie Pharmaceuticals Private Limited, buy the company report.
Recent activity
Sangie Pharmaceuticals Private Limited has 2 board changes on record since 2014: 2 appointments. The latest: Olga Madmarova was appointed as Director on 30 Dec 2014.
Frequently asked questions
Sangie Pharmaceuticals is an active private limited company based in Thane, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 30 December 2014 (12+ years old) and is registered under CIN U74900MH2014PTC260498.
Sangie Pharmaceuticals has 2 current directors:
- Snehdeep Surajbhan Kaushik - Director
- Olga Madmarova - Director
The latest financial statements of Sangie Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Sangie Pharmaceuticals is 27AAVCS2837H1ZS, registered in Maharashtra. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Sangie Pharmaceuticals is U74900MH2014PTC260498. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sangie Pharmaceuticals was incorporated on 30 December 2014, making it 12+ years old. It is registered with the Registrar of Companies, Mumbai.
Olga Madmarova was appointed as Director on 30 Dec 2014. Snehdeep Surajbhan Kaushik was appointed as Director on 30 Dec 2014.
The registered office of Sangie Pharmaceuticals is at Flat No. 304 Bldg No. 341 Sect 3 Kalptaru Srishti Mira Road Surya Shopp, Ing Centre, Thane, Maharashtra, India – 401107.
Sangie Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Sangie Pharmaceuticals is compliant as of 28 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
